 Home > Medical News > Latest Medical News > Target PD-1 and LAG-3!

Target PD-1 and LAG-3!

 Last Update: 2021-09-20
 Source: Internet
 Author: User

Tags

lantus drug class

medical

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Text|Pharmaceutical Mission Hills

The Center for Drug Evaluation (CDE) of the National Medical Products Administration of China revealed that Roche's application for a new class 1 drug RO7247669 injection has obtained an implied license for a clinical trial and is intended to be developed for the treatment of liver cancer

Screenshot source: CDE official website

A bispecific antibody is an antibody that specifically binds to two different antigens

RO7247669 is a bispecific antibody targeting PD-1 and LAG-3 developed by Roche

LAG-3 is called lymphocyte activation gene-3.

Information published on the Clinicaltrials.

Reference materials:

[1] Center for Drug Evaluation (CDE) of China National Medical Products Administration.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Delivery |, targeting PD-1 and LAG-3 at the same time, double specific new drugs enter the clinical

09-11

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

Target PD-1 and LAG-3!

Related Articles

Delivery |, targeting PD-1 and LAG-3 at the same time, double specific new drugs enter the clinical